Evidence map›Paper›PMID 15939891›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Cytoplasmic LEK1 is a regulator of microtubule function through its interaction with the LIS1 pathway.

Victor Soukoulis, Samyukta Reddy, Ryan D Pooley, Yuanyi Feng, Christopher A Walsh, David M Bader

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Regulators of the cytoplasmic dynein motor.Nature reviews. Molecular cell biology · 2009
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Bves directly interacts with GEFT, and controls cell shape and movement through regulation of Rac1/Cdc42 activity.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Victor SoukoulisStahlman Cardiovascular Research Laboratories, Program for Developmental Biology, and Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-6300, USA.
Samyukta Reddy
Ryan D Pooley
Yuanyi Feng
Christopher A Walsh
David M Bader
Harvard University · USVanderbilt University Medical Center · USHoward Hughes Medical Institute · US

Funding

Training In Cardiovascular ResearchT32HL007411 · NHLBI · VANDERBILT UNIVERSITY · PI BECKMAN, JOSHUA A · 1985 to 2020
$7.2M
REGULATION OF CARDIAC MYOCYTE DIFFERENTIATIONR01HL037675 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI BADER, DAVID M · 1986 to 2017
$4.7M
NHLBI NIH HHS HL07411NHLBI NIH HHS HL37675NHLBI NIH HHS R01 HL037675NHLBI NIH HHS T32 HL007411
6 · The paper itself

Abstract

LIS1 and nuclear distribution gene E (NudE) are partner proteins in a conserved pathway regulating the function of dynein and microtubules. Here, we present data that cytoplasmic LEK1 (cytLEK1), a large protein containing a spectrin repeat and multiple leucine zippers, is a component of this pathway through its direct interaction with NudE, as determined by a yeast two-hybrid screen. We identified the binding domains in each molecule, and coimmunoprecipitation and colocalization studies confirmed the specificity of the interaction between cytLEK1 and NudE. Confocal deconvolution analysis revealed that cytLEK1 exhibits colocalization with endogenous NudE and with the known NudE binding partners, LIS1 and dynein. By localizing the NudE-binding domain of cytLEK1 to a small domain within the molecule, we were able to disrupt cytLEK1 function by using a dominant negative approach in addition to LEK1 knockdown and, thus, examine the role of the cytLEK1-NudE interaction in cells. Consistent with a defect in the LIS1 pathway, disruption of cytLEK1 function resulted in alteration of microtubule organization and cellular shape. The microtubule network of cells became tightly focused around the nucleus and resulted in a rounded cell shape. Additionally, cells exhibited a severe inability to repolymerize their microtubule networks after nocodazole challenge. Taken together, our studies revealed that cytLEK1 is essential for cellular functions regulated by the LIS1 pathway.

Indexed as

AnimalsCarrier ProteinsChlorocebus aethiopsCOS CellsCytoplasmImmunohistochemistryMicrotubule-Associated ProteinsMicrotubulesNocodazoleOligonucleotides, AntisenseTwo-Hybrid System TechniquesCarrier ProteinsMicrotubule-Associated ProteinsNocodazoleOligonucleotides, Antisense

Identifiers

PMID15939891
PMCPMC1150833
OpenAlexW2109328712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.